American Institute for Cancer Ablation

The American Institute for Cancer Ablation (AICA) is a specialized medical facility and research center focused on the integration of interventional oncology and advanced immunotherapy. The institute utilizes image-guided ablation technologies, such as cryoablation and microwave ablation, to target and destroy primary and metastatic tumors. A key component of their approach is the administration of intratumoral immunotherapy, where checkpoint inhibitors and other agents are injected directly into the tumor site following ablation. This combined protocol is designed to release tumor antigens and stimulate a systemic immune response, potentially leading to the regression of distant untreated tumors via the abscopal effect. Led by Dr. Jason Williams, AICA provides personalized treatment options for patients with various solid tumors, including breast, lung, and pancreatic cancers.